https://www.nature.com/articles/oncsis20134Mar 25, 2013 . Effect of TKIs on ERK and AKT phosphorylation in control and gefitinib-resistant

search.ebscohost.com/login.aspx?direct=true&profile. Title: Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a

aomf.ca/pdfs/Cancer%20Research.pdfCachedSimilarthe EGFR tyrosine kinase inhibitors gefitinib and erlotinib. Ionizing radiation . ..

www.thno.org/v08p2217.htmCachedMar 8, 2018 . PPG was not only efficacious for killing Gefitinib-sensitive PC9 cells, but also for

https://academic.oup.com/carcin/article-pdf/29/7/1448/. /bgn130.pdfSimilarRad51 protein levels and protein stability in gefitinib and cisplatin or MMC

https://bmccancer.biomedcentral.com/articles/10. /1471-2407-12-95CachedSimilarAn erlotinib resistant subline (H1650-ER1) was generated upon continuous .

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423695/Feb 13, 2015 . To circumvent intrinsic variations between cell lines with respect to response to

science.sciencemag.org/highwire/filestream/586015/. /Sordella.SOM.pdfSimilarGefitinib-sensitizing EGFR Mutations in Lung Cancer Selectively. Activate .

In this study by Ono and colleagues the cell sensitivity to gefitinib correlated to

https://www.eurekaselect.com/130418/articleCachedIn this study, using NSCLC cell model H1650, we constructed a gefitinib resistant

www.oncotarget.com/fulltext/17625CachedJul 18, 2017 . Gefitinib, erlotinib or afatinib are the current treatment for . . Similarly, neither

https://www.spandidos-publications.com/etm/13/6/3067/downloadthe EGFR-TKI-resistant cell lines H1975 and H1650. The cell lines were

https://www.atcc.org/Products/All/CRL-5883.aspxCachedSimilarNCI-H1650 [H-1650, H1650] (ATCC® CRL-5883™). MoreLess. Pricing. For-Profit

https://www.sciencedirect.com/science/article/pii/S095980491300556XGefitinib-acquired resistant PC9/AB2 and NCI-H1650 (G7) cells were provided by

https://www.semanticscholar.org/. / 06f18c47e7c37bcbdbc050496693128055de7cc4Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung

https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD. /samples/CachedHomo sapiens, H1650, non sqamous cell lung cancer cell line, lung cancer,

www.readcube.com/articles/10.1038/s41419-018-0651-5We demonstrated that RNF25 mediates NF-κB activation in gefitinib-treated cells,

ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e20086Methods: Cell viability assay was performed on 4 NSCLC cell lines (A549, H1975

onlinelibrary.wiley.com/doi/10.1002/ijc.21290/pdfSimilarJul 7, 2005 . with differential sensitivity to gefitinib for activating mutations in . The egfr mutant

www.martalive.org/attach/BioChemPharm_09.pdfCachedSimilarinhibitor everolimus (RAD001) with gefitinib on a panel of NSCLC cell lines

Korea Institute of Radiological and Medical Sciences, Seoul: Combined inhibition

https://esmoopen.bmj.com/content/1/3/e000060SimilarFirst-generation EGFR-TKIs, gefitinib and erlotinib, were designed to . .

www.jitm.hk/EN/abstract/abstract85.shtmlAfter 5-aza-CdR methylation, the sensitivity of H1650 cells with EGFR mutation

pubs.rsc.org/ru/content/articlepdf/2017/bm/c7bm00035aCachedlines, namely, HCC827, A549 and H1650 cells. Cell proliferation and apoptosis

https://www.jstage.jst.go.jp/article/bpb/37/3/37_b13-00559/_. /enOn the other hand, A549, H1650 and H1975 showed much lower sensitivity to

www.pnas.org/content/pnas/102/21/7665.full.pdfMay 24, 2005 . Methods. Analysis of Recurrent NSCLC and Generation of Gefitinib-Resistant.

www.mdpi.com/1422-0067/17/2/237/htmCachedFeb 15, 2016 . EGFR; gefitinib; miRNA; non-small cell lung cancer; resistance . . attenuated

https://www.researchgate.net/. /38096958_Combined_inhibition_of_IGFR_ enhances_the_effects_of_gefitinib_in_H1650_A_lung_cancer_cell_line_wi. Dec 19, 2017 . Combined inhibition of IGFR enhances the effects of gefitinib in H1650: A lung

While PC-9 cells were more resistant to vandetanib than gefitinib, H1650 cells

https://www.hindawi.com/journals/ijpro/2011/215496/CachedSimilarJun 1, 2011 . Growth of the metastatic carcinoma cell line H1650, which harbored . . often

www.jto.org/article/S1556-0864(15)34225-8/pdfresistance to gefitinib, a resistant subline HCC827/GR was established .

https://www.pamgene.com/. / AACR%202014%20%20%23%204248%20Izawa%20et%20al.pdfCachedSimilarChemosensitivity to EGFR inhibitors (gefitinib, erlotinib, and afatinib) was

https://kundoc.com/. /cyclosporine-a-sensitizes-human-non-small-cell-lung- cancer-cells-to-gefitinib-th_5a2d1211d64ab2b65dfcdea0.htmlCachedthe anti-cancer activity of gefitinib on lung cancer cells through inhibition of

https://ir.nctu.edu.tw/bitstream/11536/8806/. /000290598200001.pdfCachedMar 13, 2011 . induction of tumor cell apoptosis (RITA), showed anti-cancer activity against

www.addexbio.com/productdetail?pid=4961CachedThe H1650 cell line was derived from the metastatic site of pleural effusion from a

https://www.ncbi.nlm.nih.gov/pubmed/19921194SimilarNov 18, 2009 . Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung

mct.aacrjournals.org/content/molcanther/5/5/1154.full.pdfSimilarEGFR mutant NSCLC cells were sensitive to gefitinib, and this was associated

www.jcpjournal.org/journal/view.html?doi=10.15430/JCP.2015. CachedSimilarMar 30, 2015 . Keywords : USP8, Non-small cell lung cancer, Gefitinib, Apoptosis, . The human

www.zagars.de/index.php?option=com_k2&view=itemlist&task. buy iressa alternative in 7 cases showing resistance to gefitinib ic50 h1650

https://www.spandidos-publications.com/or/29/5/1975/downloadwere sensitive to gefitinib. By contrast, the promoter region of the EGFR gene in

https://app.dimensions.ai/details/publication/pub.1032063482The effectiveness of gefitinib and vandetanib was assessed using a xenograft

molpharm.aspetjournals.org/content/molpharm/73/4/1290.full.pdfOct 3, 2007 . duced by drug combination (70.6% in H1650). Erlotinib sig- nificantly . . vanced

www.tmrcancer.com/EN/10.12032/TMRC201800023Mar 4, 2018 . Effect of Chinese medicine prescriptions of warming-Yang or cooling-heat

www.ingentaconnect.com/content/cog/or/pre. /content-orm-a-1564_zhangJan 31, 2018 . miR-135a confers resistance to gefitinib in non-small cell lung cancer . Methods:

https://www.jscimedcentral.com/. /plantbiology-2-1020.pdfCachedNov 24, 2014 . were resistant to both TKI and Tan IIA. H1650 and AY-01 harbor an EGFR

https://file2.selleck.jp/citations/Bortezomib-PLoS-One-20140401.pdfCachedSimilarMar 4, 2014 . The H1650 Gefitinib- resistant (H1650GR) cell line was established in our

journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed. CachedSimilarOct 30, 2007 . NSCLC cells expressing WT (H358) or mutant (HCC827, H1975, H1650, H3255)

https://www.lungcancerjournal.info/article/S0169-5002(08)00665. /abstractThe addition of celecoxib to gefitinib to prolong the survival of patients with

https://link.springer.com/article/10.1007/s00280-013-2132-ySimilarWe then focused on the gefitinib-resistant, EGFR mutant cell lines [H1650: exon

Sitemap